Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.C100325200 on June 25, 2001

J. Biol. Chem., Vol. 276, Issue 32, 30183-30187, August 10, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/32/30183    most recent
C100325200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Curcio, C.
Right arrow Articles by Bianco, A. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Curcio, C.
Right arrow Articles by Bianco, A. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

The Human Type 2 Iodothyronine Deiodinase Is a Selenoprotein Highly Expressed in a Mesothelioma Cell Line*

Cyntia Curcio, Munira M. A. Baqui, Domenico Salvatore, Bertrand H. RihnDagger , Steve MohrDagger , John W. Harney, P. Reed Larsen, and Antonio C. Bianco§

From the Department of Medicine, Thyroid Division, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115 and Dagger  Institut National de Recherche et de Securite, 54501 Vandoeuvre Cedex, France

Types 1 and 3 iodothyronine deiodinases are known to be selenocysteine-containing enzymes. Although a putative human type 2 iodothyronine deiodinase (D2) gene (hDio2) encoding a similar selenoprotein has been identified, basal D2 activity is not selenium (Se)-dependent nor has D2 been labeled with 75Se. A human mesothelioma cell line (MSTO-211H) has recently been shown to have ~40-fold higher levels of hDio2 mRNA than mesothelial cells. Mesothelioma cell lysates activate thyroxine (T4) to 3,5,3'-triiodothyronine with typical characteristics of D2 such as low Km (T4), 1.3 nM, resistance to propylthiouracil, and a short half-life (~30 min). D2 activity is ~30-fold higher in Se-supplemented than in Se-depleted medium. An antiserum prepared against a peptide deduced from the Dio2 mRNA sequence precipitates a 75Se protein of the predicted 31-kDa size from 75Se-labeled mesothelioma cells. Bromoadenosine 3'5' cyclic monophosphate increases D2 activity and 75Se-p31 ~2.5-fold whereas substrate (T4) reduces both D2 activity and 75Se-p31 ~2-3-fold. MG132 or lactacystin (10 µM), inhibitors of the proteasome pathway by which D2 is degraded, increase both D2 activity and 75Se-p31 3-4-fold and prevent the loss of D2 activity during cycloheximide or substrate (T4) exposure. Immunocytochemical studies with affinity-purified anti-hD2 antibody show a Se-dependent increase in immunofluorescence. Thus, human D2 is encoded by hDio2 and is a member of the selenodeiodinase family accounting for its highly catalytic efficiency in T4 activation.


* This work was supported by National Institutes of Health Research Grants DK36256 and DK58538.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ To whom correspondence should be addressed: Brigham and Women's Hospital, 77 Ave. Louis Pasteur, HIM Bldg. 550, Boston, MA 02115. Tel.: 617-525-5158; Fax: 617-731-4718; E-mail: abianco@rics.bwh.harvard.edu.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
B. Gereben, A. M. Zavacki, S. Ribich, B. W. Kim, S. A. Huang, W. S. Simonides, A. Zeold, and A. C. Bianco
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling
Endocr. Rev., December 1, 2008; 29(7): 898 - 938.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Piehl, T. Heberer, G. Balizs, T. S. Scanlan, R. Smits, B. Koksch, and J. Kohrle
Thyronamines Are Isozyme-Specific Substrates of Deiodinases
Endocrinology, June 1, 2008; 149(6): 3037 - 3045.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
G. D. V. Sagar, B. Gereben, I. Callebaut, J.-P. Mornon, A. Zeold, W. S. da Silva, C. Luongo, M. Dentice, S. M. Tente, B. C. G. Freitas, et al.
Ubiquitination-Induced Conformational Change within the Deiodinase Dimer Is a Switch Regulating Enzyme Activity
Mol. Cell. Biol., July 1, 2007; 27(13): 4774 - 4783.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
W. S. da-Silva, J. W. Harney, B. W. Kim, J. Li, S. D.C. Bianco, A. Crescenzi, M. A. Christoffolete, S. A. Huang, and A. C. Bianco
The Small Polyphenolic Molecule Kaempferol Increases Cellular Energy Expenditure and Thyroid Hormone Activation
Diabetes, March 1, 2007; 56(3): 767 - 776.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Zeold, M. Doleschall, M. C. Haffner, L. P. Capelo, J. Menyhert, Z. Liposits, W. S. da Silva, A. C. Bianco, I. Kacskovics, C. Fekete, et al.
Characterization of the Nuclear Factor-{kappa}B Responsiveness of the Human dio2 Gene
Endocrinology, September 1, 2006; 147(9): 4419 - 4429.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. A. Christoffolete, R. Ribeiro, P. Singru, C. Fekete, W. S. da Silva, D. F. Gordon, S. A. Huang, A. Crescenzi, J. W. Harney, E. C. Ridgway, et al.
Atypical Expression of Type 2 Iodothyronine Deiodinase in Thyrotrophs Explains the Thyroxine-Mediated Pituitary Thyrotropin Feedback Mechanism
Endocrinology, April 1, 2006; 147(4): 1735 - 1743.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. A. de Jesus, P. R. Hoffmann, T. Michaud, E. P. Forry, A. Small-Howard, R. J. Stillwell, N. Morozova, J. W. Harney, and M. J. Berry
Nuclear Assembly of UGA Decoding Complexes on Selenoprotein mRNAs: a Mechanism for Eluding Nonsense-Mediated Decay?
Mol. Cell. Biol., March 1, 2006; 26(5): 1795 - 1805.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Fekete, P. S. Singru, E. Sanchez, S. Sarkar, M. A. Christoffolete, R. S. Riberio, W. M. Rand, C. H. Emerson, A. C. Bianco, and R. M. Lechan
Differential Effects of Central Leptin, Insulin, or Glucose Administration during Fasting on the Hypothalamic-Pituitary-Thyroid Axis and Feeding-Related Neurons in the Arcuate Nucleus
Endocrinology, January 1, 2006; 147(1): 520 - 529.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont
Selenium, the Thyroid, and the Endocrine System
Endocr. Rev., December 1, 2005; 26(7): 944 - 984.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
T. Morimura, K. Tsunekawa, T. Kasahara, K. Seki, T. Ogiwara, M. Mori, and M. Murakami
Expression of Type 2 Iodothyronine Deiodinase in Human Osteoblast Is Stimulated by Thyrotropin
Endocrinology, April 1, 2005; 146(4): 2077 - 2084.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. H. A. Gouveia, M. A. Christoffolete, C. R. Zaitune, J. M. Dora, J. W. Harney, A. L. Maia, and A. C. Bianco
Type 2 Iodothyronine Selenodeiodinase Is Expressed throughout the Mouse Skeleton and in the MC3T3-E1 Mouse Osteoblastic Cell Line during Differentiation
Endocrinology, January 1, 2005; 146(1): 195 - 200.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Fekete, B. Gereben, M. Doleschall, J. W. Harney, J. M. Dora, A. C. Bianco, S. Sarkar, Z. Liposits, W. Rand, C. Emerson, et al.
Lipopolysaccharide Induces Type 2 Iodothyronine Deiodinase in the Mediobasal Hypothalamus: Implications for the Nonthyroidal Illness Syndrome
Endocrinology, April 1, 2004; 145(4): 1649 - 1655.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. W. Kim, A. M. Zavacki, C. Curcio-Morelli, M. Dentice, J. W. Harney, P. R. Larsen, and A. C. Bianco
Endoplasmic Reticulum-Associated Degradation of the Human Type 2 Iodothyronine Deiodinase (D2) is Mediated via an Association between Mammalian UBC7 and the Carboxyl Region of D2
Mol. Endocrinol., December 1, 2003; 17(12): 2603 - 2612.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. P. Peeters, H. van Toor, W. Klootwijk, Y. B. de Rijke, G. G. J. M. Kuiper, A. G. Uitterlinden, and T. J. Visser
Polymorphisms in Thyroid Hormone Pathway Genes Are Associated with Plasma TSH and Iodothyronine Levels in Healthy Subjects
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2880 - 2888.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Curcio-Morelli, B. Gereben, A. M. Zavacki, B. W. Kim, S. Huang, J. W. Harney, P. R. Larsen, and A. C. Bianco
In Vivo Dimerization of Types 1, 2, and 3 Iodothyronine Selenodeiodinases
Endocrinology, March 1, 2003; 144(3): 937 - 946.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Montero-Pedrazuela, J. Bernal, and A. Guadano-Ferraz
Divergent Expression of Type 2 Deiodinase and the Putative Thyroxine-Binding Protein p29, in Rat Brain, Suggests that They Are Functionally Unrelated Proteins
Endocrinology, March 1, 2003; 144(3): 1045 - 1052.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. W. Kim, G. H. Daniels, B. J. Harrison, A. Price, J. W. Harney, P. R. Larsen, and A. P. Weetman
Overexpression of Type 2 Iodothyronine Deiodinase in Follicular Carcinoma as a Cause of Low Circulating Free Thyroxine Levels
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 594 - 598.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Fekete, S. Sarkar, W. M. Rand, J. W. Harney, C. H. Emerson, A. C. Bianco, A. Beck-Sickinger, and R. M. Lechan
Neuropeptide Y1 and Y5 Receptors Mediate the Effects of Neuropeptide Y on the Hypothalamic-Pituitary-Thyroid Axis
Endocrinology, December 1, 2002; 143(12): 4513 - 4519.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Fekete, S. Sarkar, W. M. Rand, J. W. Harney, C. H. Emerson, A. C. Bianco, and R. M. Lechan
Agouti-Related Protein (AGRP) Has a Central Inhibitory Action on the Hypothalamic-Pituitary-Thyroid (HPT) Axis; Comparisons between the Effect of AGRP and Neuropeptide Y on Energy Homeostasis and the HPT Axis
Endocrinology, October 1, 2002; 143(10): 3846 - 3853.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Botero, B. Gereben, C. Goncalves, L. A. de Jesus, J. W. Harney, and A. C. Bianco
Ubc6p and Ubc7p Are Required for Normal and Substrate-Induced Endoplasmic Reticulum-Associated Degradation of the Human Selenoprotein Type 2 Iodothyronine Monodeiodinase
Mol. Endocrinol., September 1, 2002; 16(9): 1999 - 2007.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. Mohr, G. D. Leikauf, G. Keith, and B. H. Rihn
Microarrays as Cancer Keys: An Array of Possibilities
J. Clin. Oncol., July 15, 2002; 20(14): 3165 - 3175.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
B. Gereben, A. Kollar, J. W. Harney, and P. R. Larsen
The mRNA Structure Has Potent Regulatory Effects on Type 2 Iodothyronine Deiodinase Expression
Mol. Endocrinol., July 1, 2002; 16(7): 1667 - 1679.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser
Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor
Endocrinology, April 1, 2002; 143(4): 1190 - 1198.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
Endocr. Rev., February 1, 2002; 23(1): 38 - 89.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement